Profile data is unavailable for this security.
About the company
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The Company's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.
- Revenue in HKD (TTM)2.04bn
- Net income in HKD-253.29m
- Incorporated2016
- Employees1.54k
- LocationSichuan Kelun-Biotech Biopharmaceutical Co LtdNo. 666 Xinhua Avenue, Chengdu Cross-StrCHENGDU ChinaCHN
- Websitehttp://www.kelun-biotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TYK Medicines Inc | 0.00 | -465.66m | 9.46bn | 144.00 | -- | -- | -- | -- | -1.26 | -1.26 | 0.00 | -3.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -50.25 | -- | -- | -100.00 | -- | -22.97 | -- | -- | -- |
| Keymed Biosciences Inc | 88.85m | -808.56m | 12.50bn | 1.12k | -- | 4.36 | -- | 140.73 | -3.09 | -3.09 | 0.3398 | 10.26 | 0.0207 | 0.3115 | 7.74 | 99,051.95 | -18.86 | -- | -20.96 | -- | 68.65 | -- | -909.38 | -- | 4.83 | -- | 0.2155 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Ascentage Pharma Group International | 982.62m | -392.04m | 13.90bn | 574.00 | -- | 16.64 | -- | 14.14 | -1.36 | -1.36 | 3.38 | 2.65 | 0.2998 | 3.49 | 2.19 | 1,685,452.00 | -11.97 | -44.93 | -16.78 | -57.04 | 96.96 | 87.68 | -39.93 | -976.10 | 1.83 | -8.16 | 0.6865 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| Genscript Biotech Corp | 7.85bn | -1.38bn | 23.16bn | 7.28k | -- | 2.45 | -- | 2.95 | -0.6499 | -0.6499 | 3.71 | 4.44 | 0.3006 | 9.15 | 7.99 | 1,130,909.00 | -9.68 | -18.34 | -14.76 | -26.15 | 53.63 | 54.68 | -32.19 | -64.91 | 4.06 | -- | 0.1972 | -- | 34.17 | 29.44 | 57.91 | -- | 17.14 | -- |
| Sichuan Kelun-Biotech Biophrmctcl Co Ltd | 2.04bn | -253.29m | 39.00bn | 1.54k | -- | 11.17 | -- | 19.09 | -1.12 | -1.12 | 9.23 | 15.67 | 0.5869 | 9.46 | 167.74 | 1,443,460.00 | -7.28 | -- | -16.56 | -- | 61.81 | -- | -12.40 | -- | 5.59 | -- | 0.0118 | -- | 91.62 | -- | 6.81 | -- | -- | -- |
| Akeso Inc | 2.04bn | -800.14m | 60.99bn | 2.82k | -- | 10.35 | -- | 29.91 | -0.9525 | -0.9525 | 2.42 | 6.57 | 0.1925 | 0.3707 | 5.27 | 734,095.70 | -8.18 | -11.59 | -9.19 | -13.87 | 92.21 | -- | -42.50 | -42.49 | 4.43 | -5.49 | 0.3922 | -- | 440.35 | 337.43 | 273.60 | -- | 63.99 | -- |
| WuXi Biologics (Cayman) Inc | 18.63bn | 2.86bn | 71.13bn | 12.44k | 25.84 | 1.61 | 14.48 | 3.82 | 0.6626 | 0.6626 | 4.33 | 10.65 | 0.3163 | 5.35 | 2.98 | 1,461,931.00 | 5.57 | 8.28 | 6.85 | 10.25 | 38.66 | 43.25 | 17.60 | 27.46 | 2.62 | -- | 0.0928 | 0.00 | 11.56 | 46.38 | -23.09 | 40.07 | 20.32 | -- |
Data as of Nov 08 2024. Currency figures normalised to Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's reporting currency: Hong Kong Dollar HKD
9.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RTW Investments LPas of 10 Jul 2023 | 1.93m | 1.47% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.79m | 1.36% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024 | 1.48m | 1.13% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.26m | 0.96% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.26m | 0.96% |
| Wellington Management Hong Kong Ltd.as of 27 Nov 2023 | 1.12m | 0.85% |
| China Universal Asset Management Co., Ltd.as of 10 Jul 2023 | 1.08m | 0.82% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 968.00k | 0.74% |
| Laurion Capital Management LPas of 10 Jul 2023 | 939.60k | 0.72% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 912.70k | 0.69% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
